+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cellgen Diagnostics - Product Pipeline Analysis, 2019 Update

  • ID: 4849556
  • Company Profile
  • July 2019
  • 29 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • 3i Diagnostics Inc
  • 3rd Street Diagnostics
  • A/C Diagnostics LLC
  • Abacus Diagnostics
  • Abbott Diagnostics
  • MORE
Summary

Cellgen Diagnostics (Cellgen Diagnostics) is a healthcare service provider. It offers amplification free precision medicine platform can detect and measure multiple DNA and RNA markers. The company’s proprietary platform does not employ complicated and costly amplification methods but leverages on-chip enrichment and detection on a disposable cartridge. Its core technology leverages a proprietary sample enrichment process that uses a unique evaporating droplet technique. Cellgen Diagnostics’ pipeline products comprise biomarkers, CD panels, PD-1, PD-L1, CTLA-4, MSI, and IFN-Y, among others. The company also develops an immuno-oncology companion diagnostic platform that enables doctors to administer a simple, in-house blood test that will measure the health of the immune system. Cellgen Diagnostics is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Cellgen Diagnostics
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3i Diagnostics Inc
  • 3rd Street Diagnostics
  • A/C Diagnostics LLC
  • Abacus Diagnostics
  • Abbott Diagnostics
  • MORE
Cellgen Diagnostics Company Overview
  • Cellgen Diagnostics Company Snapshot
  • Cellgen Diagnostics Pipeline Products and Ongoing Clinical Trials Overview
  • Cellgen Diagnostics – Pipeline Analysis Overview
  • Cellgen Diagnostics - Key Facts
  • Cellgen Diagnostics - Major Products and Services
  • Cellgen Diagnostics Pipeline Products by Development Stage
  • Cellgen Diagnostics Pipeline Products Overview
  • Biomarker Assay - CD Panel
  • Biomarker Assay - CD Panel Product Overview
  • Biomarker Assay - CTLA4
  • Biomarker Assay - CTLA4 Product Overview
  • Biomarker Assay - PD1
  • Biomarker Assay - PD1 Product Overview
  • Diagnostic Assay - Breast Cancer
  • Diagnostic Assay - Breast Cancer Product Overview
  • Diagnostic Assay - Cardiovascular Disease
  • Diagnostic Assay - Cardiovascular Disease Product Overview
  • Diagnostic Assay - Colon Cancer
  • Diagnostic Assay - Colon Cancer Product Overview
  • Diagnostic Assay - Infectious Disease
  • Diagnostic Assay - Infectious Disease Product Overview
  • Diagnostic Assay - Leukemia
  • Diagnostic Assay - Leukemia Product Overview
  • Diagnostic Assay - Lung Cancer
  • Diagnostic Assay - Lung Cancer Product Overview
  • Diagnostic Assay - Multiple Sclerosis
  • Diagnostic Assay - Multiple Sclerosis Product Overview
  • Diagnostic Assay - Prostate Cancer
  • Diagnostic Assay - Prostate Cancer Product Overview
  • Diagnostic Assay - Rheumatoid Arthritis
  • Diagnostic Assay - Rheumatoid Arthritis Product Overview
  • Cellgen Diagnostics - Key Competitors
  • Cellgen Diagnostics - Key Employees
  • Cellgen Diagnostics - Locations And Subsidiaries
  • Head Office
Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • Cellgen Diagnostics Pipeline Products and Ongoing Clinical Trials Overview
  • Cellgen Diagnostics Pipeline Products by Equipment Type
  • Cellgen Diagnostics Pipeline Products by Indication
  • Cellgen Diagnostics, Key Facts
  • Cellgen Diagnostics, Major Products and Services
  • Cellgen Diagnostics Number of Pipeline Products by Development Stage
  • Cellgen Diagnostics Pipeline Products Summary by Development Stage
  • Biomarker Assay - CD Panel - Product Status
  • Biomarker Assay - CD Panel - Product Description
  • Biomarker Assay - CTLA4 - Product Status
  • Biomarker Assay - CTLA4 - Product Description
  • Biomarker Assay - PD1 - Product Status
  • Biomarker Assay - PD1 - Product Description
  • Diagnostic Assay - Breast Cancer - Product Status
  • Diagnostic Assay - Breast Cancer - Product Description
  • Diagnostic Assay - Cardiovascular Disease - Product Status
  • Diagnostic Assay - Cardiovascular Disease - Product Description
  • Diagnostic Assay - Colon Cancer - Product Status
  • Diagnostic Assay - Colon Cancer - Product Description
  • Diagnostic Assay - Infectious Disease - Product Status
  • Diagnostic Assay - Infectious Disease - Product Description
  • Diagnostic Assay - Leukemia - Product Status
  • Diagnostic Assay - Leukemia - Product Description
  • Diagnostic Assay - Lung Cancer - Product Status
  • Diagnostic Assay - Lung Cancer - Product Description
  • Diagnostic Assay - Multiple Sclerosis - Product Status
  • Diagnostic Assay - Multiple Sclerosis - Product Description
  • Diagnostic Assay - Prostate Cancer - Product Status
  • Diagnostic Assay - Prostate Cancer - Product Description
  • Diagnostic Assay - Rheumatoid Arthritis - Product Status
  • Diagnostic Assay - Rheumatoid Arthritis - Product Description
  • Cellgen Diagnostics, Key Employees
  • Glossary
List of Figures
  • Cellgen Diagnostics Pipeline Products by Equipment Type
  • Cellgen Diagnostics Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Diagnostics
  • Abacus Diagnostics
  • A/C Diagnostics LLC
  • 3rd Street Diagnostics
  • 3i Diagnostics Inc
Note: Product cover images may vary from those shown
Adroll
adroll